Induced pluripotent stem cells look just like embryonic stem cells, but are easier to create and free of the heavy ethics baggage. David Cyranoski separates fact from fiction in a burgeoning field.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Takahashi, K. & Yamanaka, S. Cell 126, 663-676 (2006).
Yu, J. et al. Science 318, 1917-1920 (2007).
Takahashi, K. et al. Cell 131, 861-872 (2007).
Hanna, J. et al. Science 318, 1920-1923 (2007).
Takagi, Y. et al. J. Clin. Invest. 115, 102-109 (2005).
Lowry, W. E. et al. Proc. Natl Acad. Sci. USA 105, 2883-2888 (2008).
Yu, J. et al. Science 318, 1917-1920 (2007).
Nayernia, K. et al. Dev. Cell 11, 125-132 (2006).
Additional information
David Cyranoski is Nature's AsiaâPacific correspondent. See Editorial, page 388.
Related links
Related links
Related external links
20 Years of Embryonic Stem Cells
Rights and permissions
About this article
Cite this article
Cyranoski, D. Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature 452, 406â408 (2008). https://doi.org/10.1038/452406a
Published:
Issue Date:
DOI: https://doi.org/10.1038/452406a
